News
Read our latest articles.
EPIK Biosciences Launches to Pioneer Ketamine-Powered Psychedelic Therapies to Transform Treatment of Mental Health, Pain, and Addiction
Advancing synergistic combination medicines, non-opioid solutions for chronic pain, neuropsychiatric disorders, and substance use disorders using patient-friendly delivery methods. AUSTIN, Texas, May 05, 2026 (GLOBE NEWSWIRE) -- EPIK Biosciences (“EPIK” or the...